Human Cytomegalovirus GB Polypeptide-Based Solutions for Environmental and Industrial Applications

This inventive concept leverages the core technology of engineered human cytomegalovirus GB polypeptides to develop novel solutions for wastewater treatment, heavy metal detection, air quality monitoring, biofuel generation, and foodborne pathogen detection.

The original patent disclosed engineered human cytomegalovirus GB polypeptides with improved stability and immunogenicity for vaccine applications. However, the limitations of the original patent are its focus on vaccine development, neglecting the potential of these polypeptides in other industries. This inventive concept addresses the need for innovative solutions in environmental and industrial fields, where the unique properties of these polypeptides can be exploited.

The newly generated claims describe a system for treating wastewater, a method for detecting heavy metals, a device for monitoring air quality, a process for generating biofuels, and a biosensor for detecting foodborne pathogens, all utilizing engineered human cytomegalovirus GB polypeptides. These polypeptides are engineered to possess at least two amino acid mutations, including at least one engineered disulfide mutation, which enables their application in these diverse fields. The mutations confer specific binding properties, allowing the polypeptides to interact with pollutants, heavy metal ions, biomass, and pathogens.

The novelty of this inventive concept lies in the application of engineered human cytomegalovirus GB polypeptides in entirely new industries, leveraging their unique properties to solve pressing environmental and industrial problems. The inventive step is the recognition of the potential of these polypeptides beyond vaccine development and the design of novel solutions that capitalize on their capabilities.

Alternative embodiments of this inventive concept could include the use of different engineered disulfide mutations, varying the number and type of amino acid mutations, or exploring other industries where the polypeptides' properties could be valuable. Variations could also involve combining the polypeptides with other technologies or materials to enhance their performance.

The commercial potential of this inventive concept is substantial, with applications in wastewater treatment, environmental monitoring, biofuel production, and food safety. The target industries include environmental remediation, industrial manufacturing, and healthcare, offering a broad market for these innovative solutions.